Spark Biomedical Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Later Stage VC
- Investors
-
14
Spark Biomedical General Information
Description
Developer of wearable neurostimulation devices designed to offer opioid withdrawal relief. The company's devices use transcutaneous auricular neurostimulation to stimulate nerves on and around the ear to overcome withdrawal, heal from addiction, and achieve a better quality of life, enabling patients to use a non-pharmaceutical approach and receive long-term recovery support.
Contact Information
Website
www.sparkbiomedical.comCorporate Office
- 18208 Preston Road
- Suite, D9 531
- Dallas, TX 75252
- United States
Corporate Office
- 18208 Preston Road
- Suite, D9 531
- Dallas, TX 75252
- United States
Spark Biomedical Timeline
Spark Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 02-Mar-2026 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series A) | 30-Apr-2025 | Completed | Generating Revenue | |||
| 9. Grant | 29-Aug-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 12-May-2023 | Completed | Generating Revenue | |||
| 7. Seed Round | 01-Jan-2022 | Completed | Generating Revenue | |||
| 6. Grant | 16-Nov-2021 | Completed | Generating Revenue | |||
| 5. Grant | 01-Aug-2021 | Completed | Generating Revenue | |||
| 4. Grant | 05-Feb-2021 | Completed | Generating Revenue | |||
| 3. Grant | 31-Aug-2020 | $218K | Completed | Generating Revenue | ||
| 2. Grant | 30-Sep-2019 | $1.25M | Completed | Generating Revenue |
Spark Biomedical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A-3 | 1,099,019 | $0.000100 | $0.58 | $0.58 | 1x | $0.58 | 3.88% | |
| Seed | 3,886,740 | $0.000100 | $0.9 | $0.9 | 1x | $0.9 | 13.73% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Spark Biomedical Comparisons
Industry
Financing
Details
Spark Biomedical Competitors (23)
One of Spark Biomedical’s 23 competitors is Mainstay Medical, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mainstay Medical | Venture Capital-Backed | San Diego, CA | ||||
| Saluda Medical | Formerly PE-Backed | Bloomington, MN | ||||
| Iovera | Formerly VC-backed | Brisbane, CA | ||||
| BrainQ | Venture Capital-Backed | Jerusalem, Israel | ||||
| Neuros Medical | Venture Capital-Backed | Aliso Viejo, CA |
Spark Biomedical Patents
Spark Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12747426-B1 | Ex-vivo enhancement of platelet function during blood processing | Active | 29-Oct-2025 | ||
| US-12752102-B1 | Disposable electrodes for portable stimulation devices and systems and methods for replacement of the disposable electrodes | Active | 17-Jun-2025 | ||
| US-12465764-B1 | Delivery of non-penetrating electrical neurostimulation therapy | Active | 30-Sep-2024 | ||
| US-20260131142-A1 | Improved delivery of non-penetrating electrical neurostimulation therapy | Pending | 30-Sep-2024 | ||
| WO-2026072777-A1 | Improved delivery of non-penetrating electrical neurostimulation therapy | Pending | 30-Sep-2024 | A61N1/36021 |
Spark Biomedical Signals
Spark Biomedical Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HIS Kingdom Resources Fund | Venture Capital | Minority | ||
| Northwell Holdings | Corporate Venture Capital | Minority | ||
| Pathway to Cures | Not-For-Profit Venture Capital | Minority | ||
| United States Department of War | Government | |||
| Southwest National Pediatric Device Innovation Consortium | Accelerator/Incubator | Minority |
Spark Biomedical FAQs
-
When was Spark Biomedical founded?
Spark Biomedical was founded in 2018.
-
Where is Spark Biomedical headquartered?
Spark Biomedical is headquartered in Dallas, TX.
-
What is the size of Spark Biomedical?
Spark Biomedical has 30 total employees.
-
What industry is Spark Biomedical in?
Spark Biomedical’s primary industry is Therapeutic Devices.
-
Is Spark Biomedical a private or public company?
Spark Biomedical is a Private company.
-
What is Spark Biomedical’s current revenue?
The current revenue for Spark Biomedical is .
-
How much funding has Spark Biomedical raised over time?
Spark Biomedical has raised $34.6M.
-
Who are Spark Biomedical’s investors?
HIS Kingdom Resources Fund, Northwell Holdings, Pathway to Cures, United States Department of War, and Southwest National Pediatric Device Innovation Consortium are 5 of 14 investors who have invested in Spark Biomedical.
-
Who are Spark Biomedical’s competitors?
Mainstay Medical, Saluda Medical, Iovera, BrainQ, and Neuros Medical are some of the 23 competitors of Spark Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process